We are live on ! Find out more
FA

FCG Advisors Portfolio holdings

AUM $425M
1-Year Est. Return 12.09%
This Fund
S&P 500
This Quarter Est. Return
+7.55%
1 Year Est. Return
+12.09%
3 Year Est. Return
+19.73%
5 Year Est. Return
+52.93%
10 Year Est. Return
AUM
$132M
AUM Growth
-$8.81M
Cap. Flow
-$16.2M
Cap. Flow %
-12.25%
Top 10 Hldgs %
56.02%
Holding
98
New
14
Increased
26
Reduced
42
Closed
12

Sector Composition

Rank Sector Weight
1 Healthcare 27.27%
2 Financials 4.6%
3 Technology 4.29%
4 Energy 3.67%
5 Consumer Staples 3.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWP icon
26
iShares Russell Mid-Cap Growth ETF
IWP
$20.2B
$1.41M 1.06%
30,462
-2,564
-8% -$110K
DVY icon
27
iShares Select Dividend ETF
DVY
$23.8B
$1.34M 1.02%
17,441
+416
+2% +$31.1K
GE icon
28
GE Aerospace
GE
$364B
$1.16M 0.88%
9,247
+366
+4% +$46.5K
OEF icon
29
iShares S&P 100 ETF
OEF
$20.1B
$1.14M 0.86%
13,124
-1,258
-9% -$106K
GLD icon
30
SPDR Gold Trust
GLD
$130B
$1.06M 0.8%
8,347
-852
-9% -$106K
IWN icon
31
iShares Russell 2000 Value ETF
IWN
$14.4B
$1M 0.76%
9,731
-46
-0.5% -$4.57K
GOOG icon
32
Alphabet (Google) Class C
GOOG
$4.22T
$997K 0.75%
34,474
-5,395
-14% -$146K
ULQ
33
DELISTED
CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF
ULQ
$949K 0.72%
+18,850
New +$949K
BMY icon
34
Bristol-Myers Squibb
BMY
$124B
$933K 0.71%
19,228
+11,565
+151% +$570K
IWO icon
35
iShares Russell 2000 Growth ETF
IWO
$14.7B
$875K 0.66%
6,320
-52
-0.8% -$6.84K
CELGZ
36
DELISTED
Celgene Corporation Contingent Value Rights
CELGZ
$841K 0.64%
323,456
-163,869
-34% -$453K
IVV icon
37
iShares Core S&P 500 ETF
IVV
$881B
$821K 0.62%
4,165
+1,175
+39% +$225K
MO icon
38
Altria Group
MO
$124B
$801K 0.61%
19,090
+15,004
+367% +$604K
MSFT icon
39
Microsoft
MSFT
$2.93T
$777K 0.59%
19,284
-2,116
-10% -$85.6K
IVW icon
40
iShares S&P 500 Growth ETF
IVW
$73.1B
$696K 0.53%
26,472
+464
+2% +$11.8K
IBM icon
41
IBM
IBM
$200B
$665K 0.5%
3,840
-187
-5% -$33.7K
ELD icon
42
WisdomTree Emerging Markets Local Debt Fund
ELD
$142M
$634K 0.48%
13,339
-3,353
-20% -$157K
YTEN
43
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$633K 0.48%
11
-2
-15% -$113K
AJG icon
44
Arthur J. Gallagher & Co
AJG
$65.2B
$623K 0.47%
13,371
VZ icon
45
Verizon
VZ
$182B
$620K 0.47%
12,663
-21
-0.2% -$1.02K
IVE icon
46
iShares S&P 500 Value ETF
IVE
$48.8B
$612K 0.46%
+6,799
New +$601K
SLB icon
47
SLB Ltd
SLB
$70.3B
$575K 0.44%
4,878
-350
-7% -$36.1K
PEG icon
48
Public Service Enterprise Group
PEG
$39.2B
$553K 0.42%
13,546
+43
+0.3% +$1.67K
T icon
49
AT&T
T
$152B
$552K 0.42%
20,661
+5,737
+38% +$154K
GSG icon
50
iShares S&P GSCI Commodity-Indexed Trust
GSG
$978M
$522K 0.4%
15,383
+839
+6% +$28K

Similar funds

FCG Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, FCG Advisors held 98 positions worth $132M, down 6.3% from $141M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

FCG Advisors withdrew a net $16.2M in Q2 2014, closing 12 positions and reducing 42 holdings. Its most notable exit was ATLAS RESOURCE PARTNERS L P COM UIT REPSTG LTD PTNRS, an estimated $2.18M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 30% a quarter earlier, followed by Financials and Technology.

Against the trend, FCG Advisors opened a new position in CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF worth $949K.

  • FCG Advisors's largest Q2 2014 buy was CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF: 18,850 shares worth $949K.
  • FCG Advisors added most to iShares MSCI EAFE ETF in Q2 2014, an estimated $1.71M increase.
  • FCG Advisors's biggest Q2 2014 reduction was Celgene Corp, cutting an estimated $15.1M.
  • FCG Advisors fully exited ATLAS RESOURCE PARTNERS L P COM UIT REPSTG LTD PTNRS in Q2 2014, selling an estimated $2.18M.
  • FCG Advisors's ten largest holdings make up 56% of its $132M portfolio in Q2 2014.
  • FCG Advisors opened 14 new positions and closed 12 in Q2 2014.
  • FCG Advisors's portfolio value fell 6.3% quarter-over-quarter to $132M.

Based on FCG Advisors's 13F filing for Q2 2014, filed 15 Aug 2014.